MAYO CLINIC ROCHESTER
Understanding and addressing the lack of and delayed screening for primary Aldosteronism
Understanding and addressing the lack of and delayed screening for primary Aldosteronism is a funding opportunity from MAYO CLINIC ROCHESTER, up to 700680, closing December 31, 2028.
Dec 31, 2028
(884d left)Overview
PROJECT SUMMARY/ABSTRACT Primary aldosteronism (PA) is the most common cause of secondary hypertension, accounting for up to 15% of cases. Compared to primary hypertension, PA is linked to a 12-fold increased risk of adverse cardiovascular and renal events and increased mortality. Despite guideline recommendations for…